Skip to content
Search AI Powered

Latest Stories

Pharmacy First service to launch next year

Pharmacy First service to launch next year

The new Pharmacy First Common Ailments service will be launched in January 2024 

This Pharmacy First Common Ailments service will help patients seek treatment for seven common conditions directly from a pharmacy without the need for a GP appointment or prescription.


Launching on 31 January next year although it is subject to IT being ready, the service will cover ailments including “sinusitis, sore throat, earache, infected insect bites, impetigo, shingles, and uncomplicated urinary tract infections (UTIs)” in women.

People with symptoms of the above seven conditions will be supplied with a prescription-only treatment under a Patient Group Direction (PGD).

Patients seeking assistance at the pharmacy, whether walk-in or referred by NHS 111, GPs, or other sources, can receive consultations.

The new service includes self-referring patients plus referrals, and the Community Pharmacist Consultation Service (CPCS) will also be a part of it.

Pharmacy First - payments 

CPE's negotiations were also aimed at key improvements for the community pharmacy including aims to "incentivise sign-up for the new services, generate capacity, reduce risk for pharmacy owners and establish conditions for business growth."

They secured an upfront payment of £2,000 per pharmacy ahead of the Pharmacy First launch to support pharmacy owners in preparing and building capacity for the new service.

Moreover, pharmacy owners gaining access to advanced clinical IT systems is like unlocking a door to seamlessly share data with the NHSBSA's MYS portal and GP records.

This is a significant move to support for the ongoing growth and improvement of community pharmacy services.

There will be fixed £1,000 monthly payments subject to £15 per consultation to support ongoing capacity to deliver Pharmacy First.

The new tripartite implementation group (CPE, DHSC, NHSE) to scrutinise the uptake and activity volumes of Pharmacy First and to set caps for the second half of 2024-25.

CPE successfully negotiated eligibility for the £1,000 Pharmacy First monthly payment to the provision of the Hypertension Case-Finding and Pharmacy Contraception Services given the capacity issues in the sector.

Janet Morrison, Chief Executive of Community Pharmacy England, said: “Our focus will now turn to getting the money flowing to pharmacies and to preparing our long-term strategy to improve the sector’s future.

"Pharmacy First will help with this strategy, laying the foundations for future clinical services and establishing the sector as an increasingly vital part of primary care, offering an open door for the public and patients, relieving pressure and releasing capacity in other frontline NHS services," she said.

Morrison further added: "This is the future that the sector told Nuffield Trust and The King’s Fund that it wanted, and this was backed by our own summer polling in which 86 per cent of respondents said they were positive about delivering a  Pharmacy First service. We all now need to work together to make it a success, delivering real value to patients and the public using all our skills and capabilities."

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less